1127 related articles for article (PubMed ID: 15519027)
21. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
[TBL] [Abstract][Full Text] [Related]
22. [Clinical features of dilated cardiomyopathy-like hypertrophic cardiomyopathy caused by a 13261 G > A mutation in cardiac myosin-binding protein C gene].
Wang SX; Zou YB; Fu CY; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):17-20. PubMed ID: 17386157
[TBL] [Abstract][Full Text] [Related]
23. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and spectrum of mutations in the sarcomeric troponin T and I genes in a cohort of Spanish cardiac hypertrophy patients.
García-Castro M; Reguero JR; Morís C; Alonso-Montes C; Berrazueta JR; Sainz R; Alvarez V; Coto E
Int J Cardiol; 2007 Sep; 121(1):115-6. PubMed ID: 17101185
[TBL] [Abstract][Full Text] [Related]
25. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
Marian AJ; Roberts R
Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
[TBL] [Abstract][Full Text] [Related]
26. [Genetic changes and clinical management in familial hypertrophic cardiomyopathy].
Domal-Kwiatkowska D; Smolik S; Mazurek U; Moric E; Polońska J; Nowalany-Kozielska E; Glanowska G; Wodniecki J; Szarek J; Wilczewski P; Kozakiewicz K; Tendera M; Wilczok T
Wiad Lek; 2000; 53(1-2):4-21. PubMed ID: 10806915
[TBL] [Abstract][Full Text] [Related]
27. [A novel missense mutation, K124N, in the troponin T gene of Chinese populations with hypertrophic cardiomyopathy].
An FS; Zhang Y; Li DQ; Yang XS; Li L; Zhang C; Yan ML; Wang Y; An GP
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1340-3. PubMed ID: 15387941
[TBL] [Abstract][Full Text] [Related]
28. Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.
Waldmüller S; Erdmann J; Binner P; Gelbrich G; Pankuweit S; Geier C; Timmermann B; Haremza J; Perrot A; Scheer S; Wachter R; Schulze-Waltrup N; Dermintzoglou A; Schönberger J; Zeh W; Jurmann B; Brodherr T; Börgel J; Farr M; Milting H; Blankenfeldt W; Reinhardt R; Özcelik C; Osterziel KJ; Loeffler M; Maisch B; Regitz-Zagrosek V; Schunkert H; Scheffold T;
Eur J Heart Fail; 2011 Nov; 13(11):1185-92. PubMed ID: 21750094
[TBL] [Abstract][Full Text] [Related]
29. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
[TBL] [Abstract][Full Text] [Related]
30. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
[TBL] [Abstract][Full Text] [Related]
32. Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish.
Zahka K; Kalidas K; Simpson MA; Cross H; Keller BB; Galambos C; Gurtz K; Patton MA; Crosby AH
Heart; 2008 Oct; 94(10):1326-30. PubMed ID: 18467358
[TBL] [Abstract][Full Text] [Related]
33. Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.
Page SP; Kounas S; Syrris P; Christiansen M; Frank-Hansen R; Andersen PS; Elliott PM; McKenna WJ
Circ Cardiovasc Genet; 2012 Apr; 5(2):156-66. PubMed ID: 22267749
[TBL] [Abstract][Full Text] [Related]
34. Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation.
Adalsteinsdottir B; Teekakirikul P; Maron BJ; Burke MA; Gudbjartsson DF; Holm H; Stefansson K; DePalma SR; Mazaika E; McDonough B; Danielsen R; Seidman JG; Seidman CE; Gunnarsson GT
Circulation; 2014 Sep; 130(14):1158-67. PubMed ID: 25078086
[TBL] [Abstract][Full Text] [Related]
35. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
[TBL] [Abstract][Full Text] [Related]
36. [A frame shift mutation, Arg346fs mutation, is identified in cardiac myosin-binding protein C gene in a Chinese family with hypertrophic cardiomyopathy].
Xie WL; Liu WL; Hu DY; Cui W; Zhu TG; Li CL; Sun YH; Li L; Bian H
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):963-6. PubMed ID: 16061003
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
Sadoul N; de Chillou C; Aliot E; McKenna WJ
Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
[TBL] [Abstract][Full Text] [Related]
38. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
[TBL] [Abstract][Full Text] [Related]
39. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
[TBL] [Abstract][Full Text] [Related]
40. The role of large gene deletions and duplications in MYBPC3 and TNNT2 in patients with hypertrophic cardiomyopathy.
Bagnall RD; Yeates L; Semsarian C
Int J Cardiol; 2010 Nov; 145(1):150-3. PubMed ID: 19666196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
